100 related articles for article (PubMed ID: 21310616)
1. Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence.
Noushi F; Spillane AJ; Uren RF; Gebski V
Breast; 2011 Jun; 20(3):278-83. PubMed ID: 21310616
[TBL] [Abstract][Full Text] [Related]
2. Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data.
Fields RC; Jeffe DB; Deshpande AD; Feunou F; Krishna N; Margenthaler JA
J Surg Res; 2010 Jun; 161(2):183-9. PubMed ID: 19959188
[TBL] [Abstract][Full Text] [Related]
3. Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms.
Noushi F; Spillane AJ; Uren RF; Gebski V
Eur J Surg Oncol; 2010 Jan; 36(1):16-22. PubMed ID: 19846271
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
Liao YQ; Xu BH
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
6. Stage migration and therapy modification after thoracoscopic internal mammary lymph node dissection in breast cancer patients.
Long H; Lin Z; Situ D; Ma G; Zheng Y; Rong T
Breast; 2011 Apr; 20(2):129-33. PubMed ID: 21036614
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of internal mammary node dissection in the treatment of breast cancer.
Horino T; Fujita M; Ueda N; Ota J; Ryo M; Nakano Y; Taguchi T
Jpn J Clin Oncol; 1991 Dec; 21(6):422-7. PubMed ID: 1805047
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
[TBL] [Abstract][Full Text] [Related]
10. Ratios of involved nodes in early breast cancer.
Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
[TBL] [Abstract][Full Text] [Related]
11. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
Oven Ustaalioglu BB; Bilici A; Kefeli U; Seker M; Yildirim E; Salepci T; Oncel M; Kement M; Gumus M
Oncology; 2010; 79(1-2):105-11. PubMed ID: 21088436
[TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
13. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
14. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
17. [Relation of tumor size, lymph node status and prognosis in breast cancer].
Shen ZZ
Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
[TBL] [Abstract][Full Text] [Related]
18. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic significance of axillary node metastasis in breast cancer].
Miura S
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
[TBL] [Abstract][Full Text] [Related]
20. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
Altinyollar H; Berberoğlu U; Gülben K; Irkin F
J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
